Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.

  • Norbert Reider
  • Published 2005 in International archives of allergy and immunology


BACKGROUND Subcutaneous specific immunotherapy (SIT) has been shown to be a causal treatment with long-term efficacy for allergic rhinoconjunctivitis and asthma, and a preventive measure against the development of asthma and new sensitizations. As it is associated with several inconveniences and serious side effects, sublingual immunotherapy (SLIT) has been… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.